NCS Multistage Q2 2026 revenue rises to $38.4 million
NCS Multistage Holdings (NCSM) reported a 5% increase in Q2 2026 revenue to $38.4 million, up from $36.5 million in Q2 2025. Despite revenue growth driven by Repeat Precision and U.S. tracer diagnostics, the company posted a net loss of $4.6 million, or $1.71 …